Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Hellman

Aviad Hellman, Matan IL

Patent application numberDescriptionPublished
20080259161Surveillance system with camera - A surveillance unit which includes a video camera (10-23-2008

Jussi Hellman, Helsinki FI

Patent application numberDescriptionPublished
20090044898Method For Manufacturing a Multimaterial Component or Construction - A method for manufacturing a multimaterial component or construction, whereby a body is formed in said method of a basic material and at least one piece formed of a wear resistant material being joined to said body at a temperature of not more than 80% of the lowest melting temperature of the materials to be joined. The invention also comprises the use of a multimaterial component or construction manufactured by means of said method.02-19-2009
20090166456Method for Manufacturing a Multimaterial Component or Construction - A method for manufacturing a multimaterial component or construction, whereby a multimaterial component or construction is manufactured comprising wear resistant material and elastomer material. The invention also includes use of a multimaterial component or construction manufactured with said method.07-02-2009

Lars Hellman, Uppsala SE

Patent application numberDescriptionPublished
20100203008NOVEL COMPOSITIONS FOR THE TREATMENT OF VERIOUS INFLAMMATORY CONDITIONS - The invention relates to compositions for the treatment of inflammatory conditions. The compositions are vaccines comprising IL-18 or fragments thereof.08-12-2010

Lars Hellman, Vardkasvagen SE

Patent application numberDescriptionPublished
20100021486TSLP VACCINE FOR THE TREATMENT OF TH2 MEDIATED INFLAMMATORY CONDITIONS - The invention relates to compositions for the treatment of TH2 mediated inflammatory conditions. The compositions are vaccines comprising a non-primate TSLP or fragments thereof to be used as a vaccine to treat humans with excessive mediated inflammatory conditions. For the treatment of TH2 mediate inflammatory conditions in other non-human mammals the TSLP of the species to be vaccinated is being used as antigen.01-28-2010

Lars T. Hellman, Uppsala SE

Patent application numberDescriptionPublished
20080262197METHODS AND MATERIALS FOR TREATING INFLAMMATORY CONDITIONS - The invention provides methods and materials for treating inflammatory conditions. Specifically, the invention provides polypeptides, isolated nucleic acids, host cells, and methods that can be used to induce an antibody response in a mammal against an antigen such as C5 or C5a. For example, the methods and materials described herein can be used to reduce the effects of C5a within a mammal by reducing the amount of total and receptor bound C5a in the mammal.10-23-2008
20090191268ALLERGY VACCINES - The invention provides methods and materials related to vaccines against self polypeptides. For example, the invention provides compositions containing chimeric IgE polypeptides and adjuvants.07-30-2009

Mats Hellman, Karlskrona SE

Patent application numberDescriptionPublished
20090111495RETREIVING AND PRESENTING INFORMATION IN A PORTABLE DEVICE - The present invention is related to a method for retrieving contacts in a portable device being arranged to operatively communicate messages and being provided with: access to a memory arrangement comprising a plurality of contacts, each being associated with one or several contact addresses for enabling a user of the portable device to communicate messages with the contact in question; a presentation arrangement for presenting contacts; and at least one control unit for controlling the operation of the portable device. The portable is arranged to perform the method, which is characterized by the steps of: monitoring the number of messages that are communicated with the device for each contact in a set of contacts among said plurality of contacts; sorting said set of contacts with respect to the number of times each contact has been involved in the communication of a message; presenting the sorted set of contacts on the presentation arrangement.04-30-2009

Ulf Hellman, Uppsala SE

Patent application numberDescriptionPublished
20080213907Protein markers for the diagnosis and prognosis of ovarian and breast cancer - Plasma samples of ovarian and breast cancer patients were used to search for markers of cancer, using two-dimensional gel electrophoresis and MALDI TOF mass spectrometry. Truncated forms of cytosolic serine hydroxymethyl transferase (cSHMT), T-box transcription factor 3 (Tbx3) and utrophin were aberrantly expressed in samples from cancer patients, as compared to samples from noncancer cases. Aberrant expression of proteins was validated by immunoblotting of plasma samples with specific antibodies to cSHMT, Tbx3 and utrophin. A cohort of 79 breast and 39 ovarian cancer patients, and 31 individuals who were either healthy or had noncancerous conditions was studied. We observed increased expression of truncated cSHMT, Tbx3 and utrophin in plasma samples obtained from patients at early stages of disease. The results indicate that cSHMT, Tbx3, utrophin and truncated forms thereof can be used as components of multiparameter monitoring of ovarian and breast cancer.09-04-2008